In a decisive move to fund one of its most significant strategic acquisitions in recent years, Abbott Laboratories has launched a massive $20 billion bond offering. The proceeds are earmarked to ...

On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...

A new automation system from Abbott, designed to improve workflows in clinical lab settings, has been granted FDA approval. The system, GLP systems Track, uses a self-propelled carrier system that ...

Abbott Laboratories (NYSE: ABT) is a diversified health care company that gives investors a great deal of stability. Between testing, nutritional products, pharmaceuticals, and medical devices, the ...

Health Canada has granted approval for Abbott’s i-STAT TBI test cartridge, enabling clinicians to evaluate suspected concussions more effectively. The authorisation allows for the use of the test ...